Work

Oral Capsule Faecal Microbiota Transplantation for Persistent Clostridioides difficile-Associated Diarrhoea Complicated by Distal Renal Tubular Acidosis: A Case Report

Year: 2026
Type: article
Abstract: Persistent, clinically non-responsive Clostridioides difficile (C. difficile) infection represents a significant clinical challenge, particularly when compounded by pre-existing metabolic disorders. We report the case of a 49-year-old female who initially presented with severe diarrhoea but tested negative for C. difficile. A week after discharge following empiric oral antibiotics, the patient re-presented with a severe worsening of diarrhoea with 40 bowel movements on admission, testing positive via a C. difficile toxin and polymerase chain reaction assay. ICU admission was warranted due to fulminant colitis, metabolic acidosis, and severe hypovolaemia. The clinical course was complicated by the patient's underlying Type 1 distal renal tubular acidosis, which exacerbated hypokalaemia with a nadir of 3.1, and severe hypoalbuminemia secondary to presumptive faecal protein loss, resulting in systemic fluid third-spacing. Following a formal surgical evaluation that opted for non-operative management on readmission day 11, sequential antimicrobial treatments, entailing standard oral vancomycin, intravenous metronidazole, and an extended course of pulsed oral fidaxomicin, failed to achieve clinical remission. On readmission day 40, an investigational multi-donor full-spectrum microbiota product (EBX-102; EnteroBiotix Ltd, Glasgow, Scotland) was accessed on a named-patient compassionate use basis and administered orally via capsules following an appropriate antibiotic washout window. The intervention was tolerated with no documented complications, leading to a steady reduction in stool frequency from 13 down to five bowel movements by post-faecal microbiota transplantation (FMT) day seven, alongside the maintenance of biochemical stability. At an extended outpatient follow-up 2 weeks post-discharge, the patient demonstrated no clinical evidence of symptomatic recurrence. This case highlights the utility of oral capsule microbiota transplantation as a potential safe inpatient intervention for persistent, clinically non-responsive C. difficile-associated diarrhoea complicated by complex metabolic abnormalities, suggesting a hypothesis that earlier deployment in continuous, severe colonic dysbiosis may prevent multi-system metabolic decompensation, a concept requiring validation in larger prospective studies.
Source: Cureus
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7233621333
FWCI:
Cites: 14
Cited by:
Related to: